SCA
RXL icon

Snowden Capital Advisors’s ProShares Ultra Health Care RXL Stock Holding History

Snowden Capital Advisors’s Portfolio RXL Stock Details RXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-1,018
Closed -$57K – 1871
2021
Q4 		$57K Buy
+1,018
New +$51.6K ﹤0.01% 997

Other funds holding RXL

IMC Chicago
IMC Chicago Chicago, Illinois $278B AUM 44.93% 1-Year Est. Return
OMC
Old Mission Capital Chicago, Illinois $6.3B AUM 14.68% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
IAN
Integrated Advisors Network Dallas, Texas $1.91B AUM 24.91% 1-Year Est. Return
PFA
Plotkin Financial Advisors Chevy Chase, Maryland $199M AUM 19.26% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
TFA
Toth Financial Advisory Leesburg, Virginia $1.02B AUM 28.36% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Snowden Capital Advisors's RXL Position: Q1 2022 in Review

Snowden Capital Advisors sold out of ProShares Ultra Health Care (RXL) in Q1 2022, closing a stake of 1,018 shares — an estimated $57K sold.

Snowden Capital Advisors first reported a position in RXL in Q4 2021 and held it in 1 quarter. The position peaked at $57K in Q4 2021. 22 funds tracked by Wall St. Rank hold RXL as of Q1 2022.

  • Snowden Capital Advisors reported no remaining ProShares Ultra Health Care position as of Q1 2022 after selling out during the quarter.
  • Snowden Capital Advisors sold 1,018 ProShares Ultra Health Care shares in Q1 2022, an estimated $57K.
  • Snowden Capital Advisors first reported a position in ProShares Ultra Health Care in Q4 2021 and held it in 1 quarter.
  • Snowden Capital Advisors's ProShares Ultra Health Care position peaked at $57K in Q4 2021.
  • 22 funds tracked by Wall St. Rank held ProShares Ultra Health Care as of Q1 2022.

Based on Snowden Capital Advisors's 13F filing for Q1 2022, filed 16 May 2022.